4.3 Article Proceedings Paper

Lymphoid chemokines in the CNS

期刊

JOURNAL OF NEUROIMMUNOLOGY
卷 224, 期 1-2, 页码 56-61

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2010.05.017

关键词

Chemokines; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Primary CNS lymphoma; Lymphoid neogenesis; Neuroborreliosis

资金

  1. NINDS NIH HHS [R01 NS047687-03, R01 NS047687-01A1, R01 NS047687-02, R01 NS047687-05, R01 NS047687, R01 NS047687-04] Funding Source: Medline

向作者/读者索取更多资源

Lymphoid chemokines, including CCL19, CCL21 and CXCL13, are critical in the development and organization of secondary lymphoid tissues and in the generation of adaptive immune responses. These molecules have also been implicated in the development of ectopic lymphoid structures in the setting of chronic inflammation. Here we review current knowledge on the production of lymphoid chemokines in the central nervous system during both homeostatic conditions and in disease states. Accumulating evidence suggests that constitutive expression of CCL19 plays a critical immunosurveillance role in healthy individuals. In contrast, aberrant induction of CCL19, CCL21 and CXCL13 may support the establishment of chronic autoimmunity and hematopoetic tumors within the CNS. (C) 2010 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据